Zdrowie i gospodarka · 21/07/2022

FDA Clears XYLOCAINE Topical Solution 4% for Continued Sale

The US Food and Drug Administration has ruled that XYLOCAINE (lidocaine hydrochloride) topical solution 4% was not withdrawn from the market due to safety or efficacy concerns, allowing it to remain available for prescription.